{"id":198551,"name":"MYRIAD GENETIC LABORATORIES INC","slug":"myriad-genetic-laboratories-inc","state":"DC","country":"United States of America","description":"Clinical laboratory.","totalSpending":180000,"filings":7,"yearlySpending":[{"year":2018,"income":180000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"}],"firms":["TODD STRATEGY GROUP"],"lobbyists":["DANIEL TODD","PAUL EDATTEL"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014.\nImplementation of changes to Medicare payment for clinical laboratory tests.\nFDA regulation of laboratory developed ","FDA draft guidance to regulate laboratory developed tests and companion diagnostics.\nLegislation to further regulate clinical labs under CLIA and/or FDA (legislation not yet introduced).","Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014.\nImplementation of changes to Medicare payment for clinical laboratory tests.\nFDA regulation of laboratory developed ","FDA draft guidance to regulate laboratory developed tests and companion diagnostics.\nLegislation to further regulate clinical labs under CLIA and/or FDA (legislation not yet introduced).","Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014.\nImplementation of changes to Medicare payment for clinical laboratory tests.\nFDA regulation of laboratory developed "]}